33 results on '"Soeiro, Thomas"'
Search Results
2. Antibiotic-induced neurological adverse drug reactions
3. Augmentation de l’abus de méthylphénidate : repérage et profils sur 13 années
4. Patterns of ketamine use among people with substance use disorder in France: Multisource analysis of the data from the French Addictovigilance Network
5. Usages et bon usage des benzodiazépines anxiolytiques et hypnotiques
6. Innovative approaches in CNS clinical drug development: Quantitative systems pharmacology
7. Non-steroidal anti-inflammatory drugs, pharmacology, and COVID-19 infection
8. Antibiotic-induced neurological adverse drug reactions
9. Evolution of doctor shopping for oxycodone in the 67 million inhabitants in France as a proxy for potential misuse or abuse
10. Systematic assessment of non‐medical use of prescription drugs using doctor‐shopping indicators: A nationwide, repeated cross‐sectional study
11. Systematic assessment of non‐medical use of prescription drugs using doctor‐shopping indicators: A nation‐wide, repeated cross‐sectional study.
12. Increase of high‐risk tramadol use and harmful consequences in France from 2013 to 2018: Evidence from the triangulation of addictovigilance data
13. Safety concerns on the abuse potential of esketamine: Multidimensional analysis of a new anti‐depressive drug on the market
14. Antidepressants abuse in subjects with opioid use disorders: A 10‐year study in the French OPPIDUM program
15. Commentary on Perry et al.: New means, new measures—without discarding all the previous ones!
16. Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell's palsy
17. Adverse drug reaction monitoring: Doing it the French way – Act II
18. Early Detection of Prescription Drug Abuse Using Doctor Shopping Monitoring From Claims Databases: Illustration From the Experience of the French Addictovigilance Network
19. Safety concerns on the abuse potential of esketamine: Multidimensional analysis of a new anti‐depressive drug on the market.
20. Antidepressants abuse in subjects with opioid use disorders: A 10‐year study in the French OPPIDUM program.
21. Quels sont médicaments psychoactifs obtenus illégalement et par quels moyens d’acquisition ? 10 ans d’observation à travers le dispositif national OPPIDUM
22. Différents profils d’usage de Méthylphénidate en population générale et importance de son abus : intérêt de la Méthode de classification à partir des bases de données de l’assurance maladie
23. Doctor shopping for methylphenidate as a proxy for misuse and potential abuse in the 67 million inhabitants in France
24. Obtention illégale de prégabaline comme proxy de l’usage non médical : analyse nationale multisource du Réseau Français d’Addictovigilance
25. Tendances nationales du comportement de doctor shopping pour l’oxycodone comme proxy de mésusage et d’abus potentiel
26. Augmentation de l’obtention illégale des médicaments opioïdes et des gabapentinoïdes : évolution en dix ans (2008–2018) d’observation à travers le dispositif national OPPIDUM
27. COVID-19 and NSAIDs: Primum non nocere
28. Doctor shopping for methylphenidate as a proxy for misuse and potential abuse in the 67 million inhabitants in France.
29. Evolution of doctor shopping for oxycodone in the 67 million inhabitants in France as a proxy for potential misuse or abuse.
30. Usage problématique de codéine ou de tramadol et hospitalisations
31. Commentary on Perry et al.: New means, new measures—without discarding all the previous ones!
32. Correction to: Patterns of Pregabalin Users from Substance Abuse Treatment Facilities: Results from the French OPPIDUM Program from 2008 to 2022.
33. [Increasing methylphenidate abuse: Tracking and profiles during 13-years].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.